Nuvilex, Inc. Pancreatic Cancer Therapy Offers Higher Survival Rate and Less Toxicity Than Competitors
May 02, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 2, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has already produced impressive results from its two independent Phase II clinical trials in patients with advanced,...
Nuvilex, Inc. Pancreatic Cancer Trials Could Make "Cell-in-a-Box" Gold Standard
April 29, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Apr 29, 2013) - While many biotech and pharmaceutical companies are designing one drug after another to address specific health problems, Nuvilex, Inc. (OTCQB: NVLX) is...
Human Clinical Trials Using Medical Marijuana Could Be Close in the U.S.
April 16, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Apr 16, 2013) - With more and more acceptance of medical marijuana here in the U.S., companies like Nuvilex, Inc. (OTCQB: NVLX), and research centers like the...
Nuvilex, Inc. Can Benefit From Passage of This Week's Medical Marijuana Bill
April 10, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Apr 10, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its subsidiary Medical Marijuana Sciences, Inc. received some good news this week as Maryland lawmakers passed a bill...